Joint United Nations Programme on HIV and AIDS — UN organization addressing HIV/AIDS response, collaborating with regional governments and partners on prevention, treatment, and global targets.
Key points drawn from coverage. Tap a point to see the original sentence.
September 2026
Informanté
UNAIDSaims atexpanding pharmaceutical manufacturing to build resilient health systems
Source
“For UNAIDS, expanding pharmaceutical manufacturing in the region is therefore aimed not only at increasing production, but also at building more resilient health systems and ensuring timely access to health innovations and essential medicines.”
“Namibia has surpassed the UNAIDS 95-95-95 targets, with 96% of people living with HIV knowing their status, 98% of those diagnosed receiving treatment and 98% of those on treatment achieving viral suppression.”
UNAIDSis participating inSADC-China strategic exchange on pharmaceutical manufacturing
Source
“The initiative brings together the Southern African Development Community (SADC), UNAIDS, the Global Health Innovation Institute (GHII), the governments of South Africa and China, Chinese pharmaceutical companies and regional and global partners.”
UNAIDSplaced Namibia among countries achievingglobal 95-95-95 HIV targets
Source
“New UNAIDS data has placed Namibia among only 11 countries worldwide to achieve the global 95-95-95 HIV targets, while warning that funding cuts, widening inequalities and threats to human rights could derail efforts to end AIDS as a public health threat by 2030.”
Joint United Nations Programme on HIV and AIDShasFast-Track targets Khomas is nearing
Source
“On HIV-AIDS, the governor said Khomas is nearing the Joint United Nations Programme on HIV and AIDS Fast-Track targets, with 94% of diagnosed patients receiving antiretroviral treatment, and 98% of those on treatment achieving viral suppression.”
UNAIDShas warned thatfailure to maintain momentum could reverse gains made over recent decades
Source
“UNAIDS has warned that failure to maintain momentum could reverse gains made over recent decades, resulting in millions of additional infections and deaths while increasing future response costs.”
Joint United Nations Programme on HIV and AIDS executive director Winnie Byanyimasays the Time100 list recognisesimpact, innovation, and achievement of the world's most influential individuals
Source
“"The Time100 list recognises the impact, innovation, and achievement of the world's most influential individuals, celebrating leaders whose contributions continue to shape the global agenda," Joint United Nations Programme on HIV and AIDS executive director Winnie Byanyima says.”
UNAIDSreports that drastic donor cuts have sentshockwaves around the world, risking reversal of progress against HIV/Aids
Source
“In a report due to be released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that drastic cuts from a number of donors have sent shockwaves around the world, and the "phenomenal progress" in tackling the illness risks being reversed.”
UNAIDSaims for95% of people living with HIV-AIDS to know their status, 95% of those diagnosed to access ART, and 95% of those on ART to achieve viral suppression by 2025
Source
“The UNAIDS 95-95-95 targets aim is for 95% of people living with HIV-AIDS to know their status, 95% of those diagnosed to access ART, and 95% of those on ART to achieve viral suppression by 2025.”
SADC, UNAIDS, China and the Global Health Innovation Institute are collaborating to expand local production of medicines, vaccines and health technologies in Southern Africa, with partners identifying priority areas to increase domestic production, reduce import reliance and strengthen regional health security.
SADC, UNAIDS, China and the Global Health Innovation Institute are collaborating to expand local production of medicines, vaccines and health technologies in Southern Africa, with partners identifying priority areas to increase domestic production, reduce import reliance and strengthen regional health security.
The United States is phasing out direct financial support for Namibia's HIV response, shifting to technical cooperation after 2027, while the government already funds 100% of antiretroviral medicines. Health experts warn that sustaining gains will require more than ARV availability, as US assistance has also covered testing, counselling, and community programmes.
Namibia and the United States announced a planned, phased reduction of US financial assistance for Namibia's HIV-AIDS response, with US support to transition over the next year from financial assistance to a technical cooperation model. This follows Namibia's achievement of HIV-AIDS epidemic control and surpassing of global targets, including reaching 96-98-98 and exceeding the UNAIDS 95-95-95 fast-track targets.
Southern Africa is deepening collaboration with China on pharmaceutical manufacturing, technology transfer and health security through a SADC-China strategic exchange taking place from 31 August to 4 September 2026 in South Africa. The initiative brings together SADC, UNAIDS, the Global Health Innovation Institute, governments and pharmaceutical companies to strengthen the region's capacity to produce medicines and health technologies.
New research published in the New England Journal of Medicine, co-authored by Nobel laureate Joseph Stiglitz and others including Monica Geingos, finds that economic inequality rather than traditional measures like laboratory capacity is the strongest predictor of how countries respond to health crises, arguing that technical capacity alone is insufficient without addressing inequality.
New UNAIDS data shows Namibia has achieved the 95-95-95 HIV targets in 2025, with 97% of people living with HIV knowing their status, 98% receiving treatment, and 98% achieving viral suppression. The report warns that funding cuts and widening inequalities threaten progress toward ending AIDS by 2030, though a significant treatment gap remains among children aged 0–14 years.
Khomas governor Sam Nujoma said the region has recorded 95% HIV status awareness among people living with HIV, while the government has committed more than N$59.2 million towards healthcare infrastructure projects including hospital renovations and upgrades.
The United Nations will hold a High-Level Meeting on HIV/AIDS on 22 and 23 June in New York to assess global progress, adopt a new Political Declaration, and set fresh targets aimed at ending AIDS as a public health threat by 2030. The meeting, held every five years since 2001, will review achievements and challenges since the 2021 Political Declaration and guide the global HIV response through 2030.
Former First Lady Monica Geingos has been appointed as an Advisor to Club de Madrid, a global forum of more than 130 democratic former Presidents and Prime Ministers from over 70 countries. Geingos brings experience in law, finance, public health, and youth development, and founded the One Economy Foundation and chairs the Organisation of African First Ladies for Development.
Former First Lady Monica Geingos has been appointed Board Chair of the Partnership for Maternal, Newborn & Child Health (PMNCH), the world's largest alliance focused on the health and well-being of women, children and adolescents. She succeeds former New Zealand Prime Minister Helen Clark, whose tenure ends in November 2026.
Monica Geingos has been appointed board chair of the Partnership for Maternal, Newborn and Child Health, the world's largest alliance focused on maternal, newborn and child health, succeeding former New Zealand prime minister Helen Clark when her term ends in November 2026. The alliance, hosted by the WHO in Geneva, brings together nearly 1,500 partner organisations working on maternal, child and adolescent health.
President Netumbo Nandi-Ndaitwah has been recognised on the Time100 list for 2026 for her influential leadership and commitment to advancing Namibia's development priorities, strengthening democratic governance, and championing inclusive economic growth. The selection spotlights Namibia's rising voice on the international stage, particularly in promoting peace, stability, and equitable progress.
Monica Geingos received an Honorary Doctorate in Philosophy from the University of Johannesburg in recognition of her work in social development, youth empowerment, and gender equity across Africa. The honour acknowledges her two decades in financial and investment sectors, her roles as founder of the One Economy Foundation and #BeFree Movement Project, and her service as UNAIDS Special Advocate and President of the Organisation of African First Ladies for Development.
During the 39th African Union Summit in Addis Ababa, President Netumbo Nandi-Ndaitwah held bilateral meetings with international partners to advance Namibia's priorities in trade and investment, HIV response and health sovereignty, climate finance and resilience, and water governance. The engagements included meetings with representatives from the United States, Arab development bank, UNAIDS, the Green Climate Fund, Ethiopia, Rwanda, and the UN.
An opinion piece argues that Namibian CSOs have become trapped in donor-dependent cycles, driven by foreign funding priorities rather than local needs, and proposes reforms including a national civil society fund, government service contracting, domestic resource mobilisation, and stronger accountability to communities rather than foreign donors.
The Ministry of Health and Social Services has approved lenacapavir, a long-acting injectable HIV preventive medicine administered twice yearly, placing Namibia among the first African countries to do so. The ministry acknowledges the drug's breakthrough potential but emphasises the need for affordable pricing to ensure equitable access across the continent, given the current global list price of over USD 28,000 per person annually.
Namibia has fast-tracked registration of lenacapavir, a long-acting injectable HIV prevention medication administered twice yearly, placing it among the first African countries to approve the next-generation pre-exposure prophylaxis option. However, Health Minister Esperance Luvindao highlighted that the drug's current global price of over US$28,000 per person per year is unaffordable for most Africans, and the ministry is engaging with the African Medicines Agency to advocate for price reductions.